Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 1
2017 1
2018 1
2019 1
2020 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group. Zeiser R, et al. N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. N Engl J Med. 2020. PMID: 32320566 Clinical Trial.
Extracorporeal Photopheresis in Graft-versus-Host Disease.
Asensi Cantó P, Sanz Caballer J, Solves Alcaína P, de la Rubia Comos J, Gómez Seguí I. Asensi Cantó P, et al. Among authors: sanz caballer j. Transplant Cell Ther. 2023 Sep;29(9):556-566. doi: 10.1016/j.jtct.2023.07.001. Epub 2023 Jul 6. Transplant Cell Ther. 2023. PMID: 37419324 Review.
Review of Cutaneous Graft-vs-Host Disease.
Ballester-Sánchez R, Navarro-Mira M, Sanz-Caballer J, Botella-Estrada R. Ballester-Sánchez R, et al. Among authors: sanz caballer j. Actas Dermosifiliogr. 2016 Apr;107(3):183-93. doi: 10.1016/j.ad.2015.10.003. Epub 2015 Nov 25. Actas Dermosifiliogr. 2016. PMID: 26626500 Free article. Review. English, Spanish.
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. J Clin Oncol. 2024 Mar 12:JCO2302474. doi: 10.1200/JCO.23.02474. Online ahead of print. J Clin Oncol. 2024. PMID: 38471061
The role of phototherapy in cutaneous chronic graft-vs-host disease: a retrospective study and review of the literature.
Ballester-Sánchez R, Navarro-Mira MÁ, de Unamuno-Bustos B, Pujol-Marco C, Sanz-Caballer J, Botella-Estrada R. Ballester-Sánchez R, et al. Among authors: sanz caballer j. Actas Dermosifiliogr. 2015 Oct;106(8):651-7. doi: 10.1016/j.ad.2015.04.009. Epub 2015 May 29. Actas Dermosifiliogr. 2015. PMID: 26032871 Free article. Review. English, Spanish.
Role of extracorporeal photopheresis in the management of children with graft-vs-host disease.
Asensi Cantó P, Sanz Caballer J, Fuentes Socorro C, Solves Alcaína P, Lloret Madrid P, Solís Ruíz J, Torres Guerola B, de la Rubia Comos J, Fernández Navarro JM, Gómez-Seguí I. Asensi Cantó P, et al. Among authors: sanz caballer j. J Clin Apher. 2022 Dec;37(6):573-583. doi: 10.1002/jca.22012. Epub 2022 Sep 22. J Clin Apher. 2022. PMID: 36134700
Real-World Experience in Extracorporeal Photopheresis for Adults with Graft-versus-Host Disease.
Asensi Cantó P, Sanz Caballer J, Sopeña Pell-Ilderton C, Solís Ruiz J, Lloret Madrid P, Villalba Montaner M, Facal Malvar A, Chorão P, Guerreiro M, Balaguer Roselló A, Montoro Gómez J, Santiago Balsera M, Solves Alcaína P, Sanz Alonso MÁ, De la Rubia Comos J, Gómez-Seguí I. Asensi Cantó P, et al. Among authors: sanz caballer j. Transplant Cell Ther. 2023 Dec;29(12):765.e1-765.e8. doi: 10.1016/j.jtct.2023.09.001. Epub 2023 Sep 12. Transplant Cell Ther. 2023. PMID: 37703997
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
Escamilla Gómez V, García-Gutiérrez V, López Corral L, García Cadenas I, Pérez Martínez A, Márquez Malaver FJ, Caballero-Velázquez T, González Sierra PA, Viguria Alegría MC, Parra Salinas IM, Calderón Cabrera C, González Vicent M, Rodríguez Torres N, Parody Porras R, Ferra Coll C, Orti G, Valcárcel Ferreiras D, De la Cámara LLanzá R, Molés P, Velázquez-Kennedy K, João Mende M, Caballero Barrigón D, Pérez E, Martino Bofarull R, Saavedra Gerosa S, Sierra J, Poch M, Zudaire Ripa MT, Díaz Pérez MA, Molina Angulo B, Sánchez Ortega I, Sanz Caballer J, Montoro Gómez J, Espigado Tocino I, Pérez-Simón JA; Grupo Español de Trasplante Hematopoyético (GETH). Escamilla Gómez V, et al. Among authors: sanz caballer j. Bone Marrow Transplant. 2020 Mar;55(3):641-648. doi: 10.1038/s41409-019-0731-x. Epub 2019 Nov 7. Bone Marrow Transplant. 2020. PMID: 31700138 Free PMC article.
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study.
Solano C, Castro-Rebollo P, Pérez-Martínez A, López-Corral L, Barba-Suñol P, Kwon M, Ortiz V, Sanz-Caballer J, Caballero AC, Martínez J, Cedillo Á, Sureda A. Solano C, et al. Among authors: sanz caballer j. BMJ Open. 2023 Jul 25;13(7):e071371. doi: 10.1136/bmjopen-2022-071371. BMJ Open. 2023. PMID: 37491085 Free PMC article.
11 results